Buy Stocks Easy | About Us
January 22, 2021
Buy Stocks Easy | Online Stocks

CYCCP


Buy Cyclacel Pharmaceuticals, Inc. Stock (symbol: CYCCP) Easy Online

Company Name: Cyclacel Pharmaceuticals, Inc.

Symbol: CYCCP

Sector: Health Care

Industry: Major Pharmaceuticals

IPO:

CYCCP Current Share Price

Today's CYCCP ( Cyclacel Pharmaceuticals, Inc. ) opening price: $5.2500

Yesterday's CYCCP ( Cyclacel Pharmaceuticals, Inc. ) closing price: $5.2500

Cyclacel Pharmaceuticals, Inc. Stock ( symbol: CYCCP ) Price Chart since IPO ():

12 Months Cyclacel Pharmaceuticals, Inc. Stock ( symbol: CYCCP ) Price Chart

Popular Questions about Cyclacel Pharmaceuticals, Inc. Public Stock ( CYCCP )

A: Cyclacel Pharmaceuticals, Inc. stock symbol (also called stock or share ticker) is CYCCP

A: Cyclacel Pharmaceuticals, Inc. IPO (Initial Public Offering) took place on

A: Cyclacel Pharmaceuticals, Inc.'s stock (CYCCP symbol) price at ther IPO (initial Public Offering) was $5.2500

Q: Is CYCCP stock worth buying at the moment?

A: The CYCCP stock performance since 2019 are rather disappointing. If you had bought 1 share of Cyclacel Pharmaceuticals, Inc. stock (symbol: CYCCP) at the beginning of 2019, at the opening share price of $, you would be left with exactly $5.2500 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Cyclacel Pharmaceuticals, Inc. Stock Easy Online

Cyclacel Pharmaceuticals, Inc. Stock Ticker Price Chart since IPO:





Cyclacel Pharmaceuticals, Inc. Stock Price Yesterday



 


Cyclacel Pharmaceuticals, Inc. Stock Price – Last Week




 


Cyclacel Pharmaceuticals, Inc. Stock Price – Last Month




 


Cyclacel Pharmaceuticals, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/09/1957780/0/en/Cyclacel-s-CYC065-and-Venetoclax-Demonstrate-Therapeutic-Potential-and-Anticancer-Activity-in-Acute-Myeloid-and-Chronic-Lymphocytic-Leukemias.html
                            

                                
Cyclacel’s CYC065 and Venetoclax Demonstrate Therapeutic Potential and Anticancer Activity in Acute Myeloid and Chronic Lymphocytic Leukemias

                                
                                
CYC065-venetoclax combination was well tolerated in AML and CLL dos...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/23/1919032/0/en/Cyclacel-Pharmaceuticals-to-Present-at-the-Ladenburg-Thalmann-2019-Healthcare-Conference.html
                            

                                
Cyclacel Pharmaceuticals to Present at the Ladenburg Thalmann 2019 Healthcare Conference

                                
                                
BERKELEY HEIGHTS, N.J., Sept.  23, 2019  (GLOBE NEWSWIRE) -- Cyclac...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/09/1912626/0/en/Cyclacel-Pharmaceuticals-Announces-First-Patient-Treated-With-Oral-CYC065-in-a-Phase-1-Study-in-Patients-With-Advanced-Solid-Tumors.html
                            

                                
Cyclacel Pharmaceuticals Announces First Patient Treated With Oral CYC065 in a Phase 1 Study in Patients With Advanced Solid Tumors

                                
                                
BERKELEY HEIGHTS, N.J., Sept.  09, 2019  (GLOBE NEWSWIRE) -- Cyclac...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/04/1910630/0/en/Cyclacel-Pharmaceuticals-to-Present-at-the-21st-Annual-H-C-Wainwright-Global-Investment-Conference.html
                            

                                
Cyclacel Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference   

                                
                                
BERKELEY HEIGHTS, N.J., Sept.  04, 2019  (GLOBE NEWSWIRE) -- Cyclac...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/09/1957780/0/en/Cyclacel-s-CYC065-and-Venetoclax-Demonstrate-Therapeutic-Potential-and-Anticancer-Activity-in-Acute-Myeloid-and-Chronic-Lymphocytic-Leukemias.html
                            

                                
Cyclacel’s CYC065 and Venetoclax Demonstrate Therapeutic Potential and Anticancer Activity in Acute Myeloid and Chronic Lymphocytic Leukemias

                                
                                
CYC065-venetoclax combination was well tolerated in AML and CLL dos...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/23/1919032/0/en/Cyclacel-Pharmaceuticals-to-Present-at-the-Ladenburg-Thalmann-2019-Healthcare-Conference.html
                            

                                
Cyclacel Pharmaceuticals to Present at the Ladenburg Thalmann 2019 Healthcare Conference

                                
                                
BERKELEY HEIGHTS, N.J., Sept.  23, 2019  (GLOBE NEWSWIRE) -- Cyclac...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/09/1912626/0/en/Cyclacel-Pharmaceuticals-Announces-First-Patient-Treated-With-Oral-CYC065-in-a-Phase-1-Study-in-Patients-With-Advanced-Solid-Tumors.html
                            

                                
Cyclacel Pharmaceuticals Announces First Patient Treated With Oral CYC065 in a Phase 1 Study in Patients With Advanced Solid Tumors

                                
                                
BERKELEY HEIGHTS, N.J., Sept.  09, 2019  (GLOBE NEWSWIRE) -- Cyclac...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/04/1910630/0/en/Cyclacel-Pharmaceuticals-to-Present-at-the-21st-Annual-H-C-Wainwright-Global-Investment-Conference.html
                            

                                
Cyclacel Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference   

                                
                                
BERKELEY HEIGHTS, N.J., Sept.  04, 2019  (GLOBE NEWSWIRE) -- Cyclac...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/09/1957780/0/en/Cyclacel-s-CYC065-and-Venetoclax-Demonstrate-Therapeutic-Potential-and-Anticancer-Activity-in-Acute-Myeloid-and-Chronic-Lymphocytic-Leukemias.html
                            

                                
Cyclacel’s CYC065 and Venetoclax Demonstrate Therapeutic Potential and Anticancer Activity in Acute Myeloid and Chronic Lymphocytic Leukemias

                                
                                
CYC065-venetoclax combination was well tolerated in AML and CLL dos...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/23/1919032/0/en/Cyclacel-Pharmaceuticals-to-Present-at-the-Ladenburg-Thalmann-2019-Healthcare-Conference.html
                            

                                
Cyclacel Pharmaceuticals to Present at the Ladenburg Thalmann 2019 Healthcare Conference

                                
                                
BERKELEY HEIGHTS, N.J., Sept.  23, 2019  (GLOBE NEWSWIRE) -- Cyclac...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/09/1912626/0/en/Cyclacel-Pharmaceuticals-Announces-First-Patient-Treated-With-Oral-CYC065-in-a-Phase-1-Study-in-Patients-With-Advanced-Solid-Tumors.html
                            

                                
Cyclacel Pharmaceuticals Announces First Patient Treated With Oral CYC065 in a Phase 1 Study in Patients With Advanced Solid Tumors

                                
                                
BERKELEY HEIGHTS, N.J., Sept.  09, 2019  (GLOBE NEWSWIRE) -- Cyclac...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/04/1910630/0/en/Cyclacel-Pharmaceuticals-to-Present-at-the-21st-Annual-H-C-Wainwright-Global-Investment-Conference.html
                            

                                
Cyclacel Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference   

                                
                                
BERKELEY HEIGHTS, N.J., Sept.  04, 2019  (GLOBE NEWSWIRE) -- Cyclac...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.